Proteomics on the diagnostic horizon

Lessons from rheumatology

Tianfu Wu, Chandra Mohan

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Rheumatology abounds in diseases that are relatively poorly understood or diseases that are not easily managed clinically. Recently DNA microarray and proteomic-based approaches have made steady inroads into the study of various rheumatic diseases. Herein we review recent proteomic approaches that have been applied to the study of rheumatic diseases. These methods include two-dimensional gel eletrophoresis/mass spectrometry (MS), multidimensional high-pressure liquid chromatography-MS/MS, capillary electrophoresis-MS/MS, surface-enhanced laser desorption/ionization-time of flight-MS/MS, and a variety of targeted antibody-based protein arrays. Although each of these different methods has its own advantages and disadvantages, the application of these proteomic tools to rheumatology has given birth to a steadily increasing panel of molecules that may have the potential to serve as early biomarkers in various rheumatic diseases.

Original languageEnglish (US)
Pages (from-to)16-25
Number of pages10
JournalAmerican Journal of the Medical Sciences
Volume333
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Rheumatology
Tandem Mass Spectrometry
Rheumatic Diseases
Proteomics
Protein Array Analysis
Capillary Electrophoresis
Oligonucleotide Array Sequence Analysis
Mass Spectrometry
Lasers
Biomarkers
Gels
High Pressure Liquid Chromatography
Parturition
Antibodies

Keywords

  • MS/MS
  • Protein microarray
  • Proteomics
  • Rheumatology
  • Two-dimensional gel electrophoresis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Proteomics on the diagnostic horizon : Lessons from rheumatology. / Wu, Tianfu; Mohan, Chandra.

In: American Journal of the Medical Sciences, Vol. 333, No. 1, 01.2007, p. 16-25.

Research output: Contribution to journalArticle

Wu, Tianfu ; Mohan, Chandra. / Proteomics on the diagnostic horizon : Lessons from rheumatology. In: American Journal of the Medical Sciences. 2007 ; Vol. 333, No. 1. pp. 16-25.
@article{8e1d266c3a424e828ab82f86c6a96703,
title = "Proteomics on the diagnostic horizon: Lessons from rheumatology",
abstract = "Rheumatology abounds in diseases that are relatively poorly understood or diseases that are not easily managed clinically. Recently DNA microarray and proteomic-based approaches have made steady inroads into the study of various rheumatic diseases. Herein we review recent proteomic approaches that have been applied to the study of rheumatic diseases. These methods include two-dimensional gel eletrophoresis/mass spectrometry (MS), multidimensional high-pressure liquid chromatography-MS/MS, capillary electrophoresis-MS/MS, surface-enhanced laser desorption/ionization-time of flight-MS/MS, and a variety of targeted antibody-based protein arrays. Although each of these different methods has its own advantages and disadvantages, the application of these proteomic tools to rheumatology has given birth to a steadily increasing panel of molecules that may have the potential to serve as early biomarkers in various rheumatic diseases.",
keywords = "MS/MS, Protein microarray, Proteomics, Rheumatology, Two-dimensional gel electrophoresis",
author = "Tianfu Wu and Chandra Mohan",
year = "2007",
month = "1",
doi = "10.1097/00000441-200701000-00003",
language = "English (US)",
volume = "333",
pages = "16--25",
journal = "The American journal of the medical sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Proteomics on the diagnostic horizon

T2 - Lessons from rheumatology

AU - Wu, Tianfu

AU - Mohan, Chandra

PY - 2007/1

Y1 - 2007/1

N2 - Rheumatology abounds in diseases that are relatively poorly understood or diseases that are not easily managed clinically. Recently DNA microarray and proteomic-based approaches have made steady inroads into the study of various rheumatic diseases. Herein we review recent proteomic approaches that have been applied to the study of rheumatic diseases. These methods include two-dimensional gel eletrophoresis/mass spectrometry (MS), multidimensional high-pressure liquid chromatography-MS/MS, capillary electrophoresis-MS/MS, surface-enhanced laser desorption/ionization-time of flight-MS/MS, and a variety of targeted antibody-based protein arrays. Although each of these different methods has its own advantages and disadvantages, the application of these proteomic tools to rheumatology has given birth to a steadily increasing panel of molecules that may have the potential to serve as early biomarkers in various rheumatic diseases.

AB - Rheumatology abounds in diseases that are relatively poorly understood or diseases that are not easily managed clinically. Recently DNA microarray and proteomic-based approaches have made steady inroads into the study of various rheumatic diseases. Herein we review recent proteomic approaches that have been applied to the study of rheumatic diseases. These methods include two-dimensional gel eletrophoresis/mass spectrometry (MS), multidimensional high-pressure liquid chromatography-MS/MS, capillary electrophoresis-MS/MS, surface-enhanced laser desorption/ionization-time of flight-MS/MS, and a variety of targeted antibody-based protein arrays. Although each of these different methods has its own advantages and disadvantages, the application of these proteomic tools to rheumatology has given birth to a steadily increasing panel of molecules that may have the potential to serve as early biomarkers in various rheumatic diseases.

KW - MS/MS

KW - Protein microarray

KW - Proteomics

KW - Rheumatology

KW - Two-dimensional gel electrophoresis

UR - http://www.scopus.com/inward/record.url?scp=33846245995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846245995&partnerID=8YFLogxK

U2 - 10.1097/00000441-200701000-00003

DO - 10.1097/00000441-200701000-00003

M3 - Article

VL - 333

SP - 16

EP - 25

JO - The American journal of the medical sciences

JF - The American journal of the medical sciences

SN - 0002-9629

IS - 1

ER -